Activated Protein C Resistance
|
0.400 |
Biomarker
|
disease |
BEFREE |
APC resistance (13.4 %) was detected to be most common in Indian RPL patients followed by PS (10.6 %), PC (9.8 %) and AT deficiency (4.31 %.).
|
25771983 |
2015 |
Activated Protein C Resistance
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
These results support a role for platelet turnover, factor V, and aAPCR in the thrombosis of ET as well as the association between JAK2 V617F allele burden and either decreased free PS or increased TF and soluble markers of platelet and endothelial activation.
|
19105233 |
2009 |
Activated Protein C Resistance
|
0.400 |
AlteredExpression
|
disease |
LHGDN |
Our objective was to study the effect of OC on the two main determinants of the APC-resistance test, free protein S and free tissue factor pathway inhibitor (TFPI).
|
18067603 |
2008 |
Activated Protein C Resistance
|
0.400 |
AlteredExpression
|
disease |
LHGDN |
Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia vera.
|
18768782 |
2008 |
Activated Protein C Resistance
|
0.400 |
Biomarker
|
disease |
BEFREE |
For congenital thrombophilia, tests evaluated comprised protein C (PC), protein S (PS), antithrombin (AT), and activated protein C resistance (APCR).
|
15706475 |
2005 |
Activated Protein C Resistance
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Furthermore, the presence of anti-protein S Abs was strongly associated with acquired APC-R (OR, 57.8; 95% CI, 8.53-391; p < 0.0001).
|
12428083 |
2002 |
Activated Protein C Resistance
|
0.400 |
Biomarker
|
disease |
CTD_human |
Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial.
|
11703344 |
2001 |
Activated Protein C Resistance
|
0.400 |
Biomarker
|
disease |
BEFREE |
The lifetime risk for VTE was 4.4 for AT versus APCR, 2.6 for AT versus PS, 2.2 for AT versus PC, 1.9 for PC versus APCR, and 1.6 for PS versus APCR.
|
10195932 |
1999 |
Activated Protein C Resistance
|
0.400 |
Biomarker
|
disease |
BEFREE |
Laboratory assays are currently available to diagnose and type hereditary thrombophilia due to deficiency or dysfunction of one of the anticoagulant factors antithrombin (AT), protein C (PC) and protein S (PS), and APC resistance without the need of DNA analysis.
|
9763348 |
1998 |
Activated Protein C Resistance
|
0.400 |
Biomarker
|
disease |
BEFREE |
Thus, four families were diagnosed with the type I PS defect and five with congenital APC-R. No combined PS/FV Leiden or type II PS defect was found.
|
9518043 |
1997 |
Activated Protein C Resistance
|
0.400 |
Biomarker
|
disease |
BEFREE |
Since the presence of activated protein C (APC) resistance has been reported to interfere with PS activity assays resulting in an apparent type II PS deficiency, we retrospectively tested a pre-transplantation frozen plasma sample for APC resistance.
|
8845465 |
1996 |
Activated Protein C Resistance
|
0.400 |
Biomarker
|
disease |
BEFREE |
Subjects previously diagnosed as having functional PS deficiency should be re-investigated for APC resistance.
|
7803245 |
1994 |